top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Chroma Medicine Secures $135M in Series B Financing to Advance Breakthrough Epigenetic Technology

1 min read

Cambridge, MA, March 1, 2023 (PRNewswire) -- Chroma Medicine, Inc., (Chroma) a genomic medicine company pioneering single-dose epigenetic editing therapeutics, today announced the completion of a $135 million Series B financing led by GV (Google Ventures), with participation from additional new investors ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, and all existing investors.

Read full article here.

Recent Posts

Gensaic and Novo Nordisk Forge $354M Partnership to Advance Precision Therapies

Cambridge, MA, March 3, 2025 (Business Wire) -- Gensaic and Novo Nordisk have formed a collaboration worth up to $354 million per...

Openwater Names Aaron Timm as CEO to Drive Growth in Portable Imaging and Therapy Devices

San Francisco, CA, March 6, 2025 (Business Wire) -- Openwater has named Aaron Timm as CEO to lead its expansion in portable medical...

AbbVie Enters Obesity Drug Race with $2.25B Licensing Deal for Gubra’s Amylin Analog

Chicago, IL, March 3, 2025 (finance yahoo) -- AbbVie has partnered with Gubra in a deal worth up to $2.25 billion to develop an amylin...

Yorumlar

Life Science Headlines

Gensaic and Novo Nordisk Forge $354M Partnership to Advance Precision Therapies

Openwater Names Aaron Timm as CEO to Drive Growth in Portable Imaging and Therapy Devices

AbbVie Enters Obesity Drug Race with $2.25B Licensing Deal for Gubra’s Amylin Analog

Nimbus Therapeutics Appoints Abbas Kazimi as CEO Amid Strategic Transition

Roche Strikes $5.3B Deal with Zealand Pharma to Expand in Obesity Market

OrganOx Secures $142M in Equity Financing to Drive Growth in Organ Technology

Valencia Technologies Announces $35M Investment and Appoints Jim Surek as CEO to Drive Growth

GSK Completes $1.15B Acquisition of IDRx to Strengthen Precision Oncology Pipeline

Boehringer Ingelheim Names Brian Hilberdink as President, U.S. Human Pharma to Drive Growth and Impact

Thermo Fisher Scientific Acquires Solventum’s Purification & Filtration Business in $4.1B Deal to Strengthen Bioprocessing Leadership

bottom of page